Join to View Full Profile
3660 Vista AveSaint Louis, MO 63110
Phone+1 314-577-8648
Fax+1 314-771-3816
Dr. Hoft is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Infectious Disease, 1989 - 1992- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1985 - 1989
University of Missouri-Columbia School of MedicineClass of 1985
Certifications & Licensure
MO State Medical License 1992 - 2025
IA State Medical License 1985 - 1993
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Study of AERAS 422 in Healthy Adults Start of enrollment: 2010 Dec 01
- Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years Start of enrollment: 2011 Feb 24
- H3N2 M2SR in Pediatric Population Start of enrollment: 2018 Aug 15
Publications & Presentations
PubMed
- Intranasal M2SR (M2-Deficient Single Replication) Influenza Vaccine Induces Broadly Reactive Mucosal Antibody Production in Adults.Lindsay Hill-Batorski, Joshua A Weiner, Margaret E Ackerman, Yasuko Hatta, Daniel F Hoft
The Journal of Infectious Diseases. 2025-02-04 - Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity.Yinyi Yu, Krystal Meza, Chase Colbert, Daniel F Hoft, Anna Jaunarajs
Vaccines. 2024-12-31 - 1 citationsReview of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report.Shobana Balasingam, Keertan Dheda, Sarah Fortune, Stephen B Gordon, Daniel Hoft
The Journal of Infectious Diseases. 2024-08-16
Press Mentions
SLU Researchers Begin Enrolling Adolescents in Mpox Vaccine Clinical TrialApril 5th, 2023- Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported StudyMarch 6th, 2023
- Founder of SLU’s Vaccine Center Receives Lifetime Honor for Career Spent Fighting Infectious DiseasesFebruary 16th, 2023
- Join now to see all
Grant Support
- Th9 cells and protective TB immunitySAINT LOUIS UNIVERSITY2022–2027
- Vaccine and Treatment Evaluation Unit at Saint Louis UniversitySAINT LOUIS UNIVERSITY2019–2026
- Universal T cell targeted influenza vaccineSAINT LOUIS UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
